Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug 29:6:232.
doi: 10.3389/fpubh.2018.00232. eCollection 2018.

Lassa Fever 2016 Outbreak in Plateau State, Nigeria-The Changing Epidemiology and Clinical Presentation

Affiliations

Lassa Fever 2016 Outbreak in Plateau State, Nigeria-The Changing Epidemiology and Clinical Presentation

Nathan Y Shehu et al. Front Public Health. .

Abstract

Lassa fever (LF) outbreaks in Nigeria mostly occur in rural areas and during the dry season, peaking between December through February. Fever is a cardinal presenting feature among the myriad manifestations of LF. Thirty four patients with clinical diagnosis of LF were analyzed. However, only 11 (32%) LASV infections were confirmed by RT-PCR. The 2016 LF outbreak showed a preferential urban occurrence and a high case fatality. Fever (≥38°C) was not detected in over a fourth of the patients at the time of examination. Bleeding diathesis was the most common presentation while abdominal pain and headache were present in more than half of the confirmed cases. Changes in the geographical distribution and clinical presentation may have implications for disease control efforts and the risk of transmission, both locally and internationally. In order to guide interventions, public health authorities should be aware that the epidemic patterns may be changing.

Keywords: Nigeria; clinical presentation; epidemiology; fever; lassa.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Frequency of the clinical features of confirmed Lassa fever patients in Jos, North central Nigeria.

Similar articles

Cited by

References

    1. McCormick J. Lassa fever. In: Saluzzo J, Dodet B. editors. Emergence and Control of Rodent-Borne Viral Diseases. Paris: Elsevier; (1999). p. 177–95.
    1. Frame JD, Baldwin JM, Gocke DJ, Troup JM. Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. Am J Trop Med Hyg. (1970) 19:670–6. 10.4269/ajtmh.1970.19.670 - DOI - PubMed
    1. McCormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES. A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis. (1987) 155:437–44. 10.1093/infdis/155.3.437 - DOI - PubMed
    1. Lukashevich IS, Clegg JC, Sidibe K. Lassa virus activity in Guinea: distribution of human antiviral antibody defined using enzyme-linked immunosorbent assay with recombinant antigen. J Med Virol. (1993) 40:210–7. 10.1002/jmv.1890400308 - DOI - PubMed
    1. Tomori O, Fabiyi A, Sorungbe A, Smith A, McCormick JB. Viral hemorrhagic fever antibodies in Nigerian populations. Am J Trop Med Hyg. (1988) 38:407–10. 10.4269/ajtmh.1988.38.407 - DOI - PubMed

LinkOut - more resources